Innovent, a leading Chinese biopharma company, is focused on developing, manufacturing, and commercializing advanced biologic drugs at affordable prices in China. Focused specifically on antibody and immuno-therapy biologics in large therapeutic areas such as oncology, Innovent has an advanced and diversified pipeline of both biosimilar and innovative drugs.
